Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	COSMIC	Related_Results
	TNFRSF14(40.0%)	exon1,c.50A>G,p.K17R	0.4	0.75	11|9	0|3	0.45000	11|9	1	2488153	2488153	A	G	germline,normal_artifact,Germline	TNFRSF14	NM_003820.4	1	c.50A>G	p.Lys17Arg	missense_variant	not_provided		not_specified		
	MTOR(1.9%)	exon4,c.401C>T,p.A134V	0.019	0.008308	367|5	150|0	0.01934	507|10	1	11317093	11317093	G	A	background	MTOR	NM_004958.4	4	c.401C>T	p.Ala134Val	missense_variant	Uncertain_significance		not_provided		
	SPEN(47.1%)	exon11,c.3272T>C,p.L1091P	0.471	0.667	11|10	0|2	0.47619	11|10	1	16256007	16256007	T	C	germline,normal_artifact,Germline	SPEN	NM_015001.3	11	c.3272T>C	p.Leu1091Pro	missense_variant	Benign		RADIO-TARTAGLIA_SYNDROME		
	CROCC(2.0%)	exon15,c.2074G>A,p.A692T	0.02	0.014	337|7	84|1	0.01552	444|7	1	17272039	17272039	G	A	contamination,haplotype,background	CROCC	NM_014675.5	15	c.2074G>A	p.Ala692Thr	missense_variant					
	MPL(1.4%)	exon7,c.1079G>A,p.S360N	0.014	0.011	375|5	112|0	0.00924	536|5	1	43812214	43812214	G	A	PASS	MPL	NM_005373.3	7	c.1079G>A	p.Ser360Asn	missense_variant					
	MUTYH(40.0%)	exon12,c.930G>C,p.Q310H	0.4	0.5	8|4	2|3	0.41176	10|7	1	45797505	45797505	C	G	contamination,germline,normal_artifact,Germline	MUTYH	NM_001048174.2	12	c.930G>C	p.Gln310His	missense_variant	Benign		Carcinoma_of_colon|Familial_adenomatous_polyposis_2|Hereditary_cancer-predisposing_syndrome|Familial_multiple_polyposis_syndrome|not_specified|not_provided		
	CDKN2C(1.2%)	exon2,c.157G>A,p.A53T	0.012	0.01	522|5	129|0	0.00681	729|5	1	51439592	51439592	G	A	PASS	CDKN2C	NM_078626.3	2	c.157G>A	p.Ala53Thr	missense_variant					
1	NRAS(0.1%)	exon4,c.437C>T,p.A146V	0.001293	0.0004404	5748|7	3044|0	0.00120	26732|32	1	115252203	115252203	G	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				COSV65746912	
1	NRAS(0.1%)	exon4,c.436G>T,p.A146S	0.0008129	0.0004334	5760|4	3026|1	0.00097	26743|26	1	115252204	115252204	C	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	4	c.436G>T	p.Ala146Ser	missense_variant					
1	NRAS(0.1%)	exon4,c.436G>A,p.A146T	0.00081	0.001487	5760|4	3026|3	0.00090	26743|24	1	115252204	115252204	C	T	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	4	c.436G>A	p.Ala146Thr	missense_variant				COSV65731978	
1	NRAS(0.1%)	exon3,c.183A>T,p.Q61H	0.000897	0.0006063	4533|4	2073|0	0.00067	18017|12	1	115256528	115256528	T	A	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.183A>T	p.Gln61His	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|Uncertain_significance(1)	Hepatocellular_carcinoma|Acute_myeloid_leukemia|Melanoma|Adrenal_cortex_carcinoma|B-cell_chronic_lymphocytic_leukemia|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Gastric_adenocarcinoma|Thyroid_tumor|Nasopharyngeal_neoplasm|Neoplasm_of_the_large_intestine|Ovarian_serous_cystadenocarcinoma|Glioblastoma|Noonan_syndrome_and_Noonan-related_syndrome|Malignant_neoplasm_of_body_of_uterus|not_provided		
1	NRAS(0.1%)	exon2,c.35G>A,p.G12D	0.001035	0.0007938	7081|8	3004|1	0.00083	29920|25	1	115258747	115258747	C	T	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Epidermal_nevus|Malignant_melanoma_of_skin|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Gastric_adenocarcinoma|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|Myelodysplastic_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|Malignant_neoplasm_of_body_of_uterus|not_provided		
	NOTCH2(1.7%)	exon34,c.6178C>T,p.R2060C	0.017	0.00892	346|6	145|0	0.01743	451|8	1	120459167	120459167	G	A	suspected_bg	NOTCH2	NM_024408.4	34	c.6178C>T	p.Arg2060Cys	missense_variant	Uncertain_significance		Hajdu-Cheney_syndrome|Alagille_syndrome_due_to_a_NOTCH2_point_mutation|not_provided		
	NOTCH2(1.9%)	exon32,c.5796C>A,p.N1932K	0.019	0.02	327|6	70|0	0.01659	415|7	1	120461162	120461162	G	T	PASS	NOTCH2	NM_024408.4	32	c.5796C>A	p.Asn1932Lys	missense_variant					
	NOTCH2(1.8%)	exon8,c.1346C>T,p.A449V	0.018	0.014	333|6	92|0	0.01818	432|8	1	120510163	120510163	G	A	suspected_bg	NOTCH2	NM_024408.4	8	c.1346C>T	p.Ala449Val	missense_variant					
-	NOTCH2(44.4%)	exon1,c.17_18del,p.P6fs	0.444	0.486	7|6	2|1	0.50000	8|8	1	120612002	120612004	CGG	C	clustered_events,contamination,germline,haplotype,normal_artifact	NOTCH2	NM_024408.4	1	c.17_18del	p.Pro6fs	frameshift_variant	Benign/Likely_benign		not_specified		
	MCL1(2.2%)	exon3,c.980G>A,p.G327D	0.022	0.057	337|8	43|1	0.01975	397|8	1	150549924	150549924	C	T	contamination,normal_artifact,orientation,distinguished	MCL1	NM_021960.5	3	c.980G>A	p.Gly327Asp	missense_variant					
	LORICRIN(2.7%)	exon2,c.103G>A,p.G35S	0.027	0.05	135|4	18|0	0.01961	200|4	1	153233528	153233528	G	A	clustered_events,orientation	LORICRIN	NM_000427.3	2	c.103G>A	p.Gly35Ser	missense_variant					
	LORICRIN(29.0%)	exon2,c.153C>T,p.C51=	0.29	0.25	20|9	2|0	0.31250	33|15	1	153233578	153233578	C	T	clustered_events,germline,Germline	LORICRIN	NM_000427.3	2	c.153C>T	p.Cys51=	synonymous_variant	Benign		not_provided		
	SPTA1(1.2%)	exon23,c.3230G>A,p.R1077H	0.012	0.008504	760|7	158|0	0.00676	1029|7	1	158622402	158622402	C	T	PASS	SPTA1	NM_003126.4	23	c.3230G>A	p.Arg1077His	missense_variant	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(5)|Likely_benign(1)	Pyropoikilocytosis,_hereditary|Elliptocytosis_2|Hereditary_spherocytosis_type_3|not_provided		
	PIK3C2B(1.3%)	exon7,c.1236C>T,p.T412=	0.013	0.016	479|5	96|0	0.01149	602|7	1	204433214	204433214	G	A	PASS	PIK3C2B	NM_002646.4	7	c.1236C>T	p.Thr412=	synonymous_variant					
	PIK3C2B(24.3%)	exon4,c.886C>T,p.R296*	0.243	0.032	81|24	35|0	0.22131	95|27	1	204438045	204438045	G	A	PASS	PIK3C2B	NM_002646.4	4	c.886C>T	p.Arg296*	stop_gained					
	IKBKE(69.6%)	exon18,c.1805C>T,p.A602V	0.696	0.291	7|23	6|2	0.71875	9|23	1	206665052	206665052	C	T	germline,normal_artifact,Germline	IKBKE	NM_014002.4	18	c.1805C>T	p.Ala602Val	missense_variant				COSV65622897	
	AKT3(1.6%)	exon10,c.835C>T,p.L279=	0.016	0.019	287|4	75|0	0.01153	343|4	1	243727135	243727135	G	A	PASS	AKT3	NM_005465.7	10	c.835C>T	p.Leu279=	synonymous_variant				COSV55634431	
	SOX11(2.9%)	exon1,c.1138C>T,p.Q380*	0.029	0.031	172|4	44|0	0.01754	224|4	2	5833991	5833991	C	T	PASS	SOX11	NM_003108.4	1	c.1138C>T	p.Gln380*	stop_gained					
	DNMT3A(2.1%)	exon3,c.113G>A,p.R38H	0.021	0.018	303|6	78|0	0.02771	421|12	2	25523072	25523072	C	T	PASS	DNMT3A	NM_022552.5	3	c.113G>A	p.Arg38His	missense_variant	Uncertain_significance		Tall_stature-intellectual_disability-facial_dysmorphism_syndrome		
	ALK(0.9%)	exon14,c.2485A>G,p.K829E	0.00943	0.007586	444|4	161|0	0.00889	669|6	2	29456433	29456433	T	C	PASS	ALK	NM_004304.5	14	c.2485A>G	p.Lys829Glu	missense_variant&splice_region_variant					
	EPCAM(0.2%)	exon3,c.211G>A,p.A71T	0.001928	0.001032	8515|16	4990|5	0.00128	57069|73	2	47600973	47600973	G	A	low_allele_frac	EPCAM	NM_002354.3	3	c.211G>A	p.Ala71Thr	missense_variant					
-	MSH2(1.8%)	exon2,c.212-5_212-4del	0.018	0.025	1255|32	339|12	0.01712	2699|47	2	47635523	47635525	CTT	C	multiallelic,normal_artifact	MSH2	NM_000251.3	2	c.212-5_212-4del		splice_region_variant&intron_variant	Likely_benign		not_specified		
-	MSH2(10.9%)	exon2,c.212-4del	0.109	0.126	1255|207	339|67	0.11711	2699|358	2	47635523	47635525	CTT	CT	multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	2	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_1|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	MSH2(7.3%)	exon2,c.212-4dup	0.073	0.085	1255|134	339|45	0.10213	2699|307	2	47635523	47635525	CTT	CTTT	multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	2	c.212-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_1|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer		
-	MSH2(0.9%)	exon2,c.212-5_212-4dup	0.008583	0.007273	1255|13	339|3	0.00990	2699|27	2	47635523	47635525	CTT	CTTTT	multiallelic,normal_artifact	MSH2	NM_000251.3	2	c.212-5_212-4dup		splice_region_variant&intron_variant					
-	MSH2(1.3%)	exon7,c.1120C>T,p.Q374*	0.013	0.01	301|4	109|0	0.00839	473|4	2	47656924	47656924	C	T	orientation	MSH2	NM_000251.3	7	c.1120C>T	p.Gln374*	stop_gained	Pathogenic		Lynch_syndrome|Lynch_syndrome_1|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided		
	MSH6(2.3%)	exon4,c.923G>A,p.G308D	0.023	0.027	329|8	84|1	0.01965	449|9	2	48026045	48026045	G	A	normal_artifact,distinguished	MSH6	NM_000179.3	4	c.923G>A	p.Gly308Asp	missense_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms		
-	MSH6(4.5%)	exon5,c.3261del,p.F1088fs	0.045	0.043	3373|201	1213|57	0.03765	10021|392	2	48030639	48030640	AC	A	normal_artifact,slippage,suspected_bg	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Lynch_syndrome_5|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided		
-	MSH6(13.1%)	exon7,c.3557-4del	0.131	0.175	83|14	26|4	0.12381	92|13	2	48032740	48032741	AT	A	contamination,haplotype,normal_artifact,slippage,suspected_bg	MSH6	NM_000179.3	7	c.3557-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_5|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	MSH6(6.0%)	exon7,c.3557-3A>T	0.06	0.043	100|6	32|0	0.06504	115|8	2	48032754	48032754	A	T	contamination,haplotype,suspected_bg	MSH6	NM_000179.3	7	c.3557-3A>T		splice_region_variant&intron_variant	Benign		Carcinoma_of_colon|Lynch_syndrome|Lynch_syndrome_5|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|not_provided		
	XPO1(1.2%)	exon2,c.122C>T,p.A41V	0.012	0.009447	566|7	129|0	0.00860	807|7	2	61760911	61760911	G	A	PASS	XPO1	NM_003400.4	2	c.122C>T	p.Ala41Val	missense_variant					
	ANKRD36(0.4%)	exon50,c.3038A>G,p.K1013R	0.004151	0.00386	2893|10	608|2	0.00425	5157|22	2	97869977	97869977	A	G	low_allele_frac	ANKRD36	NM_001354587.1	50	c.3038A>G	p.Lys1013Arg	missense_variant					
	RANBP2(0.9%)	exon20,c.4304G>A,p.C1435Y	0.009239	0.005523	888|7	223|0	0.00689	1298|9	2	109381299	109381299	G	A	PASS	RANBP2	NM_006267.5	20	c.4304G>A	p.Cys1435Tyr	missense_variant					
	RANBP2(2.8%)	exon20,c.5175A>G,p.E1725=	0.028	0.062	258|8	19|0	0.02993	389|12	2	109382170	109382170	A	G	contamination,haplotype,background	RANBP2	NM_006267.5	20	c.5175A>G	p.Glu1725=	synonymous_variant	Likely_benign		Familial_acute_necrotizing_encephalopathy|not_provided		
	LRP1B(2.3%)	exon91,c.13687G>A,p.A4563T	0.023	0.011	346|6	118|0	0.01348	439|6	2	140990868	140990868	C	T	contamination,orientation	LRP1B	NM_018557.3	91	c.13687G>A	p.Ala4563Thr	missense_variant				COSV67256023	
	LRP1B(1.0%)	exon86,c.13145G>A,p.C4382Y	0.01	0.016	612|5	172|2	0.00629	790|5	2	141027913	141027913	C	T	normal_artifact	LRP1B	NM_018557.3	86	c.13145G>A	p.Cys4382Tyr	missense_variant&splice_region_variant					
	LRP1B(1.1%)	exon55,c.8693G>A,p.C2898Y	0.011	0.005805	843|6	229|0	0.00861	1267|11	2	141259413	141259413	C	T	PASS	LRP1B	NM_018557.3	55	c.8693G>A	p.Cys2898Tyr	missense_variant				COSV104431911	
	LRP1B(54.0%)	exon46,c.7587C>T,p.T2529=	0.54	0.005449	357|403	209|0	0.53729	546|634	2	141294205	141294205	G	A	PASS	LRP1B	NM_018557.3	46	c.7587C>T	p.Thr2529=	synonymous_variant					
	LRP1B(2.0%)	exon42,c.6824C>T,p.A2275V	0.02	0.031	298|5	86|1	0.02332	377|9	2	141359184	141359184	G	A	normal_artifact,distinguished	LRP1B	NM_018557.3	42	c.6824C>T	p.Ala2275Val	missense_variant					
	PDK1(1.2%)	exon4,c.563G>A,p.R188H	0.012	0.014	500|6	95|0	0.00922	645|6	2	173429383	173429383	G	A	background	PDK1	NM_002610.5	4	c.563G>A	p.Arg188His	missense_variant				COSV56375338	
	PDK1(0.9%)	exon9,c.966C>T,p.G322=	0.008928	0.008198	866|7	173|0	0.00802	1237|10	2	173451026	173451026	C	T	background	PDK1	NM_002610.5	9	c.966C>T	p.Gly322=	synonymous_variant				COSV56374373	
	NFE2L2(1.0%)	exon3,c.365T>C,p.L122P	0.009645	0.007873	953|9	161|0	0.00628	1424|9	2	178098015	178098015	A	G	PASS	NFE2L2	NM_006164.5	3	c.365T>C	p.Leu122Pro	missense_variant					
	SF3B1(1.0%)	exon17,c.2490C>T,p.Y830=	0.01	0.006676	881|9	201|0	0.00703	1271|9	2	198266130	198266130	G	A	PASS	SF3B1	NM_012433.4	17	c.2490C>T	p.Tyr830=	synonymous_variant					
	BMPR2(0.7%)	exon12,c.1748del,p.N583fs	0.007463	0.005294	3732|36	1011|13	0.00864	8831|77	2	203420129	203420130	GA	G	suspected_bg,low_allele_frac	BMPR2	NM_001204.7	12	c.1748del	p.Asn583fs	frameshift_variant	Pathogenic		Pulmonary_arterial_hypertension|Primary_pulmonary_hypertension|Idiopathic_and/or_familial_pulmonary_arterial_hypertension		
	ERBB4(2.8%)	exon28,c.3788G>A,p.S1263N	0.028	0.014	213|5	76|0	0.01695	290|5	2	212248479	212248479	C	T	PASS	ERBB4	NM_005235.3	28	c.3788G>A	p.Ser1263Asn	missense_variant				COSV104654204	
	ERBB4(1.6%)	exon24,c.2932G>A,p.A978T	0.016	0.028	352|5	87|1	0.01075	460|5	2	212286764	212286764	C	T	normal_artifact	ERBB4	NM_005235.3	24	c.2932G>A	p.Ala978Thr	missense_variant				COSV61523929	
	BARD1(1.2%)	exon4,c.590A>G,p.K197R	0.012	0.011	475|5	119|0	0.02552	611|16	2	215646008	215646008	T	C	background	BARD1	NM_000465.4	4	c.590A>G	p.Lys197Arg	missense_variant					
	CUL3(1.3%)	exon16,c.2282G>A,p.R761H	0.013	0.011	477|5	125|0	0.00774	641|5	2	225338987	225338987	C	T	background	CUL3	NM_003590.5	16	c.2282G>A	p.Arg761His	missense_variant				COSV52361289	
	CUL3(0.9%)	exon4,c.467G>A,p.C156Y	0.008987	0.009919	658|6	132|0	0.00656	909|6	2	225379401	225379401	C	T	PASS	CUL3	NM_003590.5	4	c.467G>A	p.Cys156Tyr	missense_variant					
	UGT1A1(1.3%)	exon0,c.-55_-54insAT	0.013	0.012	3715|58	1973|27	0.00960	22708|220	2	234668879	234668881	CAT	CATAT	clustered_events,multiallelic,normal_artifact,suspected_bg,chemotherapy_site	UGT1A1	NM_000463.3	0	c.-55_-54insAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity|drug_response|other	Pathogenic(8)|Uncertain_significance(1)|Benign(3)	Gilbert_syndrome|Lucey-Driscoll_syndrome|Crigler-Najjar_syndrome,_type_II|Crigler-Najjar_syndrome_type_1|Bilirubin,_serum_level_of,_quantitative_trait_locus_1|Irinotecan_response|not_specified|not_provided		
2	FANCD2(3.1%)	exon6,c.378-5del	0.031	0.035	437|48	140|10	0.09507	752|79	3	10076842	10076844	CTT	CT	germline,multiallelic,normal_artifact,suspected_bg	FANCD2	NM_001018115.3	6	c.378-5del		splice_region_variant&intron_variant					
2	FANCD2(1.4%)	exon6,c.378-5dup	0.014	0.018	437|24	140|6	0.04930	752|39	3	10076842	10076844	CTT	CTTT	germline,multiallelic,normal_artifact,suspected_bg	FANCD2	NM_001018115.3	6	c.378-5dup		splice_region_variant&intron_variant					
	FANCD2(1.5%)	exon19,c.1744G>A,p.A582T	0.015	0.022	390|5	56|0	0.01014	488|5	3	10102065	10102065	G	A	PASS	FANCD2	NM_001018115.3	19	c.1744G>A	p.Ala582Thr	missense_variant					
	TGFBR2(9.8%)	exon4,c.458del,p.K153fs	0.098	0.1	1387|176	245|29	0.09360	2266|234	3	30691871	30691872	GA	G	multiallelic,normal_artifact,slippage,background	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|Benign(3)|Likely_benign(1)	Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|not_provided		
	CTNNB1(0.5%)	exon4,c.378T>C,p.A126=	0.005245	0.013	1069|6	263|3	0.00389	1538|6	3	41266581	41266581	T	C	normal_artifact,low_allele_frac	CTNNB1	NM_001904.4	4	c.378T>C	p.Ala126=	synonymous_variant	Likely_benign		not_provided		
	ANO10(3.5%)	exon2,c.132del,p.D45fs	0.035	0.033	3819|163	1134|42	0.03270	10650|360	3	43647212	43647213	CT	C	contamination,multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided		
	ANO10(1.4%)	exon2,c.132dup,p.D45fs	0.014	0.018	3819|86	1134|29	0.02168	10650|236	3	43647212	43647213	CT	CTT	contamination,multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Abnormal_central_motor_function|Autosomal_recessive_spinocerebellar_ataxia_10|Autosomal_recessive_cerebellar_ataxia|not_provided		
	EPHA3(2.1%)	exon5,c.1128C>T,p.C376=	0.021	0.013	342|7	98|0	0.01927	458|9	3	89391062	89391062	C	T	distinguished	EPHA3	NM_005233.6	5	c.1128C>T	p.Cys376=	synonymous_variant					
	PIK3CB(0.8%)	exon15,c.1997G>A,p.G666D	0.008358	0.008963	1068|7	289|1	0.00487	1634|8	3	138409881	138409881	C	T	PASS	PIK3CB	NM_006219.3	15	c.1997G>A	p.Gly666Asp	missense_variant					
	ATR(6.1%)	exon10,c.2320del,p.I774fs	0.061	0.045	5690|448	2404|146	0.05223	22412|1235	3	142274739	142274740	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided		
	ATR(1.9%)	exon10,c.2320dup,p.I774fs	0.019	0.03	5690|163	2404|101	0.04488	22412|1053	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic/Likely_pathogenic		not_provided		
	PRKCI(1.4%)	exon5,c.440G>A,p.R147H	0.014	0.02	333|4	75|0	0.00922	430|4	3	169985778	169985778	G	A	PASS	PRKCI	NM_002740.6	5	c.440G>A	p.Arg147His	missense_variant					
1	PIK3CA(0.1%)	exon10,c.1624G>A,p.E542K	0.0009255	0.001651	6036|4	2370|2	0.00074	21626|16	3	178936082	178936082	G	A	clustered_events,orientation,weak_evidence,suspected_bg	PIK3CA	NM_006218.4	10	c.1624G>A	p.Glu542Lys	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Carcinoma_of_esophagus|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Gastric_adenocarcinoma|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Prostate_adenocarcinoma|Squamous_cell_carcinoma_of_the_head_and_neck|CLOVES_syndrome|CLAPO_syndrome|Glioblastoma|Lip_and_oral_cavity_carcinoma|Overgrowth_syndrome_and/or_cerebral_malformations_due_to_abnormalities_in_MTOR_pathway_genes|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|not_provided		
	KLHL6(2.3%)	exon5,c.1151G>A,p.G384D	0.023	0.016	412|8	84|0	0.01455	542|8	3	183212066	183212066	C	T	PASS	KLHL6	NM_130446.4	5	c.1151G>A	p.Gly384Asp	missense_variant					
	KLHL6(3.8%)	exon1,c.290T>C,p.F97S	0.038	0.034	101|4	34|0	0.02797	139|4	3	183273152	183273152	A	G	orientation	KLHL6	NM_130446.4	1	c.290T>C	p.Phe97Ser	missense_variant					
	BCL6(1.1%)	exon4,c.299G>A,p.G100D	0.011	0.008147	474|5	144|0	0.00816	729|6	3	187449581	187449581	C	T	PASS	BCL6	NM_001706.5	4	c.299G>A	p.Gly100Asp	missense_variant					
	MUC4(40.1%)	exon2,c.9914_9961del,p.V3305_S3320del	0.401	0.23	96|66	10|2	0.36364	7|4	3	195508489	195508537	GCTGAGGAAGCGTCGGTGACAAGAAGAGGAGTGGCGTGACCTGTGGATA	G	clustered_events,germline,haplotype,normal_artifact	MUC4	NM_018406.7	2	c.9914_9961del	p.Val3305_Ser3320del	disruptive_inframe_deletion	Pathogenic		Hepatocellular_carcinoma|Small_cell_lung_carcinoma|Lung_cancer		
1	KIT(0.1%)	exon13,c.1924A>G,p.K642E	0.001337	0.0008408	4703|6	3146|2	0.00135	22234|30	4	55594221	55594221	A	G	clustered_events,weak_evidence	KIT	NM_000222.3	13	c.1924A>G	p.Lys642Glu	missense_variant	Pathogenic		Melanoma|Hematologic_neoplasm|Malignant_melanoma_of_skin|Gastric_adenocarcinoma|Gastrointestinal_stromal_tumor|Gastrointestinal_stromal_tumor,_familial		
	EPHA5(1.5%)	exon7,c.1586G>A,p.G529D	0.015	0.007392	515|6	187|0	0.00847	702|6	4	66280103	66280103	C	T	PASS	EPHA5	NM_004439.8	7	c.1586G>A	p.Gly529Asp	missense_variant					
	EPHA5(1.2%)	exon5,c.1091C>T,p.A364V	0.012	0.006335	660|6	225|0	0.00634	941|6	4	66356406	66356406	G	A	background	EPHA5	NM_004439.8	5	c.1091C>T	p.Ala364Val	missense_variant					
	TET2(1.0%)	exon3,c.3399C>T,p.C1133=	0.009985	0.007967	840|8	309|1	0.00785	1264|10	4	106158498	106158498	C	T	PASS	TET2	NM_001127208.3	3	c.3399C>T	p.Cys1133=	synonymous_variant					
-	FBXW7(26.8%)	exon4,c.585-5del	0.268	0.384	33|15	1|2	0.26761	52|19	4	153268227	153268228	CA	C	germline,multiallelic,normal_artifact,slippage,suspected_bg	FBXW7	NM_033632.3	4	c.585-5del		splice_region_variant&intron_variant					
-	FBXW7(19.4%)	exon4,c.585-5dup	0.194	0.3	33|11	1|1	0.17460	52|11	4	153268227	153268228	CA	CAA	germline,multiallelic,normal_artifact,slippage,distinguished	FBXW7	NM_033632.3	4	c.585-5dup		splice_region_variant&intron_variant					
	FAT1(1.7%)	exon19,c.11244C>T,p.C3748=	0.017	0.008396	490|7	151|0	0.01531	643|10	4	187524436	187524436	G	A	PASS	FAT1	NM_005245.4	19	c.11244C>T	p.Cys3748=	synonymous_variant				COSV71674892	
	FAT1(0.9%)	exon14,c.9770G>A,p.R3257Q	0.008908	0.002814	1071|9	439|0	0.00772	1927|15	4	187532623	187532623	C	T	PASS	FAT1	NM_005245.4	14	c.9770G>A	p.Arg3257Gln	missense_variant					
	FAT1(1.4%)	exon13,c.9398C>A,p.T3133N	0.014	0.007536	403|5	158|0	0.00861	576|5	4	187534328	187534328	G	T	haplotype	FAT1	NM_005245.4	13	c.9398C>A	p.Thr3133Asn	missense_variant					
	FAT1(1.0%)	exon10,c.5585C>T,p.A1862V	0.009844	0.004413	922|8	316|0	0.00534	1491|8	4	187542155	187542155	G	A	background	FAT1	NM_005245.4	10	c.5585C>T	p.Ala1862Val	missense_variant					
	FAT1(1.1%)	exon9,c.4628G>A,p.R1543H	0.011	0.00638	508|6	189|0	0.01043	759|8	4	187549490	187549490	C	T	background	FAT1	NM_005245.4	9	c.4628G>A	p.Arg1543His	missense_variant				COSV104716869	
	SDHA(12.9%)	exon9,c.1235G>A,p.G412D	0.129	0.084	41|6	10|0	0.11321	47|6	5	235429	235429	G	A	PASS	SDHA	NM_004168.4	9	c.1235G>A	p.Gly412Asp	missense_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome		
	TERT(0.8%)	exon10,c.2593C>T,p.R865C	0.008392	0.016	1115|10	166|1	0.00625	1591|10	5	1266640	1266640	G	A	normal_artifact,orientation	TERT	NM_198253.3	10	c.2593C>T	p.Arg865Cys	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(2)|Uncertain_significance(1)	Dyskeratosis_congenita,_autosomal_dominant_2|Hereditary_cancer-predisposing_syndrome|Dyskeratosis_congenita|Interstitial_lung_disease_2|not_provided		
	TERT(74.0%)	exon9,c.2520G>A,p.L840=	0.74	0.333	11|35	1|0	0.73469	13|36	5	1268697	1268697	C	T	PASS	TERT	NM_198253.3	9	c.2520G>A	p.Leu840=	synonymous_variant	Benign/Likely_benign		Aplastic_anemia|Dyskeratosis_congenita,_autosomal_dominant_2|Pulmonary_fibrosis_and/or_bone_marrow_failure,_Telomere-related,_1|Hereditary_cancer-predisposing_syndrome|Dyskeratosis_congenita|Interstitial_lung_disease_2|not_specified		
	FGF10(2.3%)	exon2,c.365C>T,p.A122V	0.023	0.011	795|17	246|1	0.01530	1223|19	5	44310593	44310593	G	A	normal_artifact,distinguished	FGF10	NM_004465.2	2	c.365C>T	p.Ala122Val	missense_variant					
	MAP3K1(1.4%)	exon12,c.2101C>T,p.L701=	0.014	0.013	327|4	100|0	0.00983	403|4	5	56176551	56176551	C	T	PASS	MAP3K1	NM_005921.2	12	c.2101C>T	p.Leu701=	synonymous_variant					
	MSH3(1.0%)	exon7,c.1148del,p.K383fs	0.01	0.014	4270|63	1993|41	0.01391	14036|198	5	79970914	79970915	CA	C	multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic/Likely_pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|not_provided		
	MSH3(1.2%)	exon7,c.1148dup,p.N385fs	0.012	0.022	4270|71	1993|53	0.01585	14036|226	5	79970914	79970915	CA	CAA	multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|not_provided		
-	APC(1.4%)	exon5,c.423-5_423-4del	0.014	0.017	560|8	189|3	0.00843	941|8	5	112111309	112111311	TAA	T	multiallelic,normal_artifact	APC	NM_000038.6	5	c.423-5_423-4del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome		
-	APC(14.5%)	exon5,c.423-4del	0.145	0.115	560|116	189|31	0.16578	941|187	5	112111309	112111311	TAA	TA	multiallelic,normal_artifact,suspected_bg	APC	NM_000038.6	5	c.423-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hepatocellular_carcinoma|Gastric_cancer|Colorectal_cancer|Hereditary_cancer-predisposing_syndrome|Gastric_adenocarcinoma_and_proximal_polyposis_of_the_stomach|Familial_adenomatous_polyposis_1|Desmoid_disease,_hereditary|not_specified|not_provided		
-	APC(7.2%)	exon5,c.423-4dup	0.072	0.072	560|59	189|21	0.09693	941|101	5	112111309	112111311	TAA	TAAA	multiallelic,normal_artifact,suspected_bg	APC	NM_000038.6	5	c.423-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Hepatocellular_carcinoma|Gastric_cancer|Colorectal_cancer|Hereditary_cancer-predisposing_syndrome|Gastric_adenocarcinoma_and_proximal_polyposis_of_the_stomach|Familial_adenomatous_polyposis_1|Desmoid_disease,_hereditary|not_specified		
-	APC(0.5%)	exon10,c.1269G>A,p.W423*	0.005101	0.006098	1854|10	646|4	0.00527	3588|19	5	112154998	112154998	G	A	normal_artifact,background,low_allele_frac	APC	NM_000038.6	10	c.1269G>A	p.Trp423*	stop_gained	Pathogenic		Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1	COSV57366795	
-	APC(82.2%)	exon16,c.3956del,p.P1319fs	0.822	0.003624	122|566	305|0	0.80136	205|827	5	112175245	112175246	TC	T	PASS	APC	NM_000038.6	16	c.3956del	p.Pro1319fs	frameshift_variant	Pathogenic		Colorectal_cancer|Familial_adenomatous_polyposis_1|not_provided		
	RAD50(5.6%)	exon13,c.2165del,p.K722fs	0.056	0.046	6144|416	3570|208	0.04955	38309|1997	5	131931451	131931452	TA	T	multiallelic,normal_artifact,suspected_bg	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome		
	RAD50(1.2%)	exon13,c.2165dup,p.E723fs	0.012	0.021	6144|121	3570|96	0.02648	38309|1042	5	131931451	131931452	TA	TAA	multiallelic,normal_artifact,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided		
	CSF1R(94.2%)	exon8,c.1085A>G,p.H362R	0.942	0.167	2|51	17|2	0.96364	2|53	5	149450132	149450132	T	C	germline,normal_artifact,Germline	CSF1R	NM_005211.4	8	c.1085A>G	p.His362Arg	missense_variant&splice_region_variant	Benign		Hereditary_diffuse_leukoencephalopathy_with_spheroids|not_provided		
	NSD1(1.1%)	exon2,c.46T>C,p.F16L	0.011	0.011	576|6	127|0	0.01353	729|10	5	176562150	176562150	T	C	PASS	NSD1	NM_022455.5	2	c.46T>C	p.Phe16Leu	missense_variant					
	NSD1(1.0%)	exon9,c.4331G>A,p.G1444D	0.01	0.008182	610|6	168|0	0.00931	851|8	5	176671224	176671224	G	A	background	NSD1	NM_022455.5	9	c.4331G>A	p.Gly1444Asp	missense_variant					
	FLT4(83.3%)	exon19,c.2670C>G,p.H890Q	0.833	0.667	0|5	0|1	1.00000	0|5	5	180046344	180046344	G	C	clustered_events,germline,normal_artifact	FLT4	NM_182925.5	19	c.2670C>G	p.His890Gln	missense_variant	Benign		Hereditary_lymphedema_type_I|Congenital_heart_defects,_multiple_types,_7|not_specified|not_provided		
	CYP21A2(92.9%)	exon1,c.138C>A,p.P46=	0.929	0.246	0|22	5|2	1.00000	0|24	6	32006337	32006337	C	A	germline,haplotype,normal_artifact,Germline	CYP21A2	NM_000500.9	1	c.138C>A	p.Pro46=	synonymous_variant	Benign		Classic_congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency|not_specified		
	FANCE(88.9%)	exon2,c.387A>C,p.P129=	0.889	0.25	0|10	5|2	1.00000	0|13	6	35423662	35423662	A	C	germline,normal_artifact,Germline	FANCE	NM_021922.3	2	c.387A>C	p.Pro129=	synonymous_variant	Benign		Fanconi_anemia_complementation_group_E|not_specified|not_provided		
	EPHA7(1.8%)	exon9,c.1771G>A,p.E591K	0.018	0.009271	345|5	160|0	0.01082	457|5	6	93973605	93973605	C	T	chemotherapy_site	EPHA7	NM_004440.4	9	c.1771G>A	p.Glu591Lys	missense_variant					
	CCN6(4.0%)	exon5,c.624dup,p.C209fs	0.04	0.073	174|5	65|4	0.03271	207|7	6	112389433	112389433	G	GA	contamination,normal_artifact,slippage,weak_evidence,distinguished	CCN6	NM_003880.4	5	c.624dup	p.Cys209fs	frameshift_variant	Pathogenic		Progressive_pseudorheumatoid_dysplasia|not_provided		
	ESR1(1.2%)	exon8,c.1706C>T,p.A569V	0.012	0.004966	793|10	445|2	0.00948	1359|13	6	152420019	152420019	C	T	PASS	ESR1	NM_000125.4	8	c.1706C>T	p.Ala569Val	missense_variant					
	PMS2(0.1%)	exon11,c.1588C>T,p.Q530*	0.001417	0.0006757	6951|11	1818|0	0.00123	21092|26	7	6026808	6026808	G	A	clustered_events,low_allele_frac	PMS2	NM_000535.7	11	c.1588C>T	p.Gln530*	stop_gained	Pathogenic		Hereditary_cancer-predisposing_syndrome		
2	PMS2(13.3%)	exon7,c.706-6_706-4del	0.133	0.116	437|583	65|75	0.24479	2752|892	7	6037057	6037060	GAAA	G	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	7	c.706-6_706-4del		splice_region_variant&intron_variant	Benign		Malignant_tumor_of_breast|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|not_provided		
	INHBA(0.3%)	exon2,c.331G>A,p.A111T	0.003132	0.004024	5242|17	857|3	0.00337	14511|49	7	41739642	41739642	C	T	low_allele_frac	INHBA	NM_002192.4	2	c.331G>A	p.Ala111Thr	missense_variant					
1	EGFR(0.2%)	exon20,c.2369C>T,p.T790M	0.002328	0.00513	2585|5	515|2	0.00112	4462|5	7	55249071	55249071	C	T	clustered_events,normal_artifact,orientation,weak_evidence	EGFR	NM_005228.5	20	c.2369C>T	p.Thr790Met	missense_variant	drug_response		Non-small_cell_lung_carcinoma|Lung_carcinoma|Lung_cancer|Hereditary_cancer-predisposing_syndrome|Nonsmall_cell_lung_cancer,_resistance_to_tyrosine_kinase_inhibitor_in|EGFR-related_lung_cancer|Tyrosine_kinase_inhibitor_response|erlotinib_response_-_Efficacy|gefitinib_response_-_Efficacy|not_provided		
1	EGFR(0.2%)	exon20,c.2387G>A,p.G796D	0.001831	0.00533	2562|4	505|2	0.00112	4473|5	7	55249089	55249089	G	A	clustered_events,normal_artifact,weak_evidence	EGFR	NM_005228.5	20	c.2387G>A	p.Gly796Asp	missense_variant	Uncertain_significance		EGFR-related_lung_cancer		
	TMEM60(0.8%)	exon2,c.231A>G,p.K77=	0.007576	0.003129	3770|25	872|1	0.03656	7854|298	7	77423460	77423460	T	C	background,low_allele_frac	TMEM60	NM_032936.4	2	c.231A>G	p.Lys77=	synonymous_variant					
	MAGI2(94.7%)	exon22,c.4329C>G,p.P1443=	0.947	0.5	0|24	0|0	1.00000	0|24	7	77648671	77648671	G	C	germline,Germline	MAGI2	NM_012301.4	22	c.4329C>G	p.Pro1443=	synonymous_variant	Benign		Nephrotic_syndrome_15|not_specified|not_provided		
	MAGI2(1.0%)	exon13,c.2278C>T,p.P760S	0.01	0.007938	829|8	178|0	0.00875	1133|10	7	77814979	77814979	G	A	PASS	MAGI2	NM_012301.4	13	c.2278C>T	p.Pro760Ser	missense_variant					
	GRM3(1.1%)	exon3,c.513C>T,p.Y171=	0.011	0.008374	572|5	170|0	0.00631	787|5	7	86415621	86415621	C	T	PASS	GRM3	NM_000840.3	3	c.513C>T	p.Tyr171=	synonymous_variant					
	CDK6(1.1%)	exon7,c.743C>T,p.A248V	0.011	0.029	619|5	94|1	0.00612	812|5	7	92247477	92247477	G	A	background	CDK6	NM_001145306.2	7	c.743C>T	p.Ala248Val	missense_variant					
	PIK3CG(1.6%)	exon8,c.2691C>T,p.G897=	0.016	0.023	405|6	61|0	0.01569	502|8	7	106523539	106523539	C	T	PASS	PIK3CG	NM_002649.3	8	c.2691C>T	p.Gly897=	synonymous_variant					
0	MET(0.1%)	exon14,c.2908C>T,p.R970C	0.001209	0.001204	12896|17	5260|6	0.00074	72627|54	7	116411923	116411923	C	T	clustered_events,normal_artifact	MET	NM_000245.4	14	c.2908C>T	p.Arg970Cys	missense_variant	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(3)|Benign(6)|Likely_benign(6)	Hepatocellular_carcinoma|Neoplasm|Renal_cell_carcinoma|Renal_cell_carcinoma,_papillary,_1|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
1	MET(0.1%)	exon14,c.3028+1G>A	0.0009597	0.0002211	12119|10	6335|0	0.00087	92262|80	7	116412044	116412044	G	A	clustered_events,orientation,weak_evidence	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided		
1	BRAF(0.1%)	exon15,c.1798G>A,p.V600M	0.0009001	0.0003757	8320|7	3654|0	0.00091	40766|37	7	140453137	140453137	C	T	clustered_events,weak_evidence	BRAF	NM_004333.6	15	c.1798G>A	p.Val600Met	missense_variant	Likely_pathogenic		Melanoma|Non-small_cell_lung_carcinoma|not_provided		
	KEL(1.9%)	exon4,c.293C>T,p.A98V	0.019	0.017	320|6	72|0	0.01474	401|6	7	142658122	142658122	G	A	PASS	KEL	NM_000420.3	4	c.293C>T	p.Ala98Val	missense_variant					
-	KMT2C(5.4%)	exon38,c.8390del,p.K2797fs	0.054	0.056	7325|493	3008|212	0.05005	32854|1731	7	151874147	151874148	CT	C	contamination,multiallelic,normal_artifact,slippage,suspected_bg	KMT2C	NM_170606.3	38	c.8390del	p.Lys2797fs	frameshift_variant	Pathogenic		Small_cell_lung_carcinoma		
-	KMT2C(2.1%)	exon38,c.8390dup,p.E2798fs	0.021	0.031	7325|222	3008|118	0.03781	32854|1291	7	151874147	151874148	CT	CTT	contamination,multiallelic,normal_artifact,slippage,suspected_bg	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided		
	KMT2C(11.1%)	exon16,c.2763A>G,p.L921=	0.111	0.111	50|4	9|0	0.06780	55|4	7	151932908	151932908	T	C	contamination,haplotype,background	KMT2C	NM_170606.3	16	c.2763A>G	p.Leu921=	synonymous_variant				COSV51454345	
	KMT2C(6.4%)	exon7,c.925C>T,p.P309S	0.064	0.057	1803|122	317|19	0.07835	2682|228	7	151970877	151970877	G	A	clustered_events,contamination,map_qual,normal_artifact,background	KMT2C	NM_170606.3	7	c.925C>T	p.Pro309Ser	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|Uncertain_significance(1)	Toe_walking|Lung_cancer		
	PRKDC(1.4%)	exon86,c.12164C>T,p.P4055L	0.014	0.013	310|4	93|0	0.01743	451|8	8	48689420	48689420	G	A	PASS	PRKDC	NM_006904.7	86	c.12164C>T	p.Pro4055Leu	missense_variant					
	PRKDC(2.3%)	exon31,c.3621G>A,p.W1207*	0.023	0.023	196|4	56|0	0.01556	253|4	8	48805925	48805925	C	T	PASS	PRKDC	NM_006904.7	31	c.3621G>A	p.Trp1207*	stop_gained					
	LYN(1.5%)	exon10,c.1018C>T,p.L340=	0.015	0.008855	625|6	150|0	0.00895	886|8	8	56882320	56882320	C	T	PASS	LYN	NM_002350.4	10	c.1018C>T	p.Leu340=	synonymous_variant					
	PREX2(2.2%)	exon14,c.1554C>T,p.D518=	0.022	0.018	300|6	86|0	0.01626	363|6	8	68984790	68984790	C	T	PASS	PREX2	NM_024870.4	14	c.1554C>T	p.Asp518=	synonymous_variant					
	PREX2(1.3%)	exon28,c.3446G>A,p.R1149H	0.013	0.008257	479|6	169|0	0.00923	644|6	8	69031691	69031691	G	A	PASS	PREX2	NM_024870.4	28	c.3446G>A	p.Arg1149His	missense_variant				COSV55802043	
	PREX2(1.7%)	exon37,c.4587C>T,p.C1529=	0.017	0.007978	339|5	151|0	0.01008	491|5	8	69104743	69104743	C	T	PASS	PREX2	NM_024870.4	37	c.4587C>T	p.Cys1529=	synonymous_variant					
	RUNX1T1(4.2%)	exon8,c.1101del,p.G368fs	0.042	0.013	190|10	83|0	0.03891	247|10	8	92998418	92998419	CT	C	distinguished	RUNX1T1	NM_175635.3	8	c.1101del	p.Gly368fs	frameshift_variant					
	JAK2(1.1%)	exon13,c.1719G>A,p.L573=	0.011	0.016	558|6	81|0	0.00870	684|6	9	5072569	5072569	G	A	PASS	JAK2	NM_004972.4	13	c.1719G>A	p.Leu573=	synonymous_variant					
	PDCD1LG2(1.1%)	exon3,c.126C>T,p.C42=	0.011	0.016	590|6	88|0	0.00826	720|6	9	5534815	5534815	C	T	PASS	PDCD1LG2	NM_025239.4	3	c.126C>T	p.Cys42=	synonymous_variant					
	FANCC(1.4%)	exon2,c.115G>A,p.A39T	0.014	0.016	379|5	77|0	0.01584	497|8	9	98011459	98011459	C	T	PASS	FANCC	NM_000136.3	2	c.115G>A	p.Ala39Thr	missense_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome		
	PTCH1(1.2%)	exon10,c.1403C>T,p.A468V	0.012	0.006039	686|9	210|0	0.00966	1025|10	9	98239929	98239929	G	A	background	PTCH1	NM_000264.5	10	c.1403C>T	p.Ala468Val	missense_variant					
	ABL1(2.2%)	exon11,c.1826_1828del,p.K609del	0.022	0.04	596|13	116|3	0.01945	958|19	9	133759489	133759492	CAAG	C	contamination,normal_artifact,slippage,suspected_bg	ABL1	NM_005157.6	11	c.1826_1828del	p.Lys609del	disruptive_inframe_deletion	Pathogenic		Lung_cancer		
	TSC1(1.2%)	exon23,c.3018G>A,p.G1006=	0.012	0.008838	734|8	164|0	0.00817	971|8	9	135772099	135772099	C	T	PASS	TSC1	NM_000368.5	23	c.3018G>A	p.Gly1006=	synonymous_variant					
-	TSC1(16.3%)	exon21,c.2626-5_2626-4del	0.163	0.141	51|52	17|9	0.09187	603|61	9	135773000	135773002	GAA	G	multiallelic,normal_artifact	TSC1	NM_000368.5	21	c.2626-5_2626-4del		splice_region_variant&intron_variant	Benign		Isolated_focal_cortical_dysplasia_type_II|Tuberous_sclerosis_1|Lymphangiomyomatosis|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	TSC1(24.6%)	exon21,c.2626-4del	0.246	0.096	51|68	17|6	0.16017	603|115	9	135773000	135773002	GAA	GA	multiallelic,normal_artifact,distinguished	TSC1	NM_000368.5	21	c.2626-4del		splice_region_variant&intron_variant	Benign		Isolated_focal_cortical_dysplasia_type_II|Tuberous_sclerosis_syndrome|Tuberous_sclerosis_1|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	TSC1(15.9%)	exon21,c.2626-5_2626-4dup	0.159	0.116	51|35	17|8	0.15900	603|114	9	135773000	135773002	GAA	GAAAA	multiallelic,normal_artifact	TSC1	NM_000368.5	21	c.2626-5_2626-4dup		splice_region_variant&intron_variant	Benign		Isolated_focal_cortical_dysplasia_type_II|Tuberous_sclerosis_1|Lymphangiomyomatosis|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
	TSC1(53.4%)	exon3,c.69C>T,p.D23=	0.534	0.004219	487|562	292|0	0.53758	763|887	9	135804191	135804191	G	A	PASS	TSC1	NM_000368.5	3	c.69C>T	p.Asp23=	synonymous_variant	Benign/Likely_benign		Tuberous_sclerosis_1|Hereditary_cancer-predisposing_syndrome		
	NOTCH1(2.4%)	exon27,c.5115G>A,p.A1705=	0.024	0.028	252|5	41|0	0.02280	300|7	9	139397686	139397686	C	T	clustered_events,contamination,distinguished	NOTCH1	NM_017617.5	27	c.5115G>A	p.Ala1705=	synonymous_variant	Likely_benign		not_provided		
-	NOTCH1(27.3%)	exon25,c.4419_4422dup,p.D1475fs	0.273	0.067	62|19	16|0	0.21782	79|22	9	139399925	139399925	C	CCCAG	PASS	NOTCH1	NM_017617.5	25	c.4419_4422dup	p.Asp1475fs	frameshift_variant					
	NOTCH1(2.0%)	exon15,c.2388G>A,p.A796=	0.02	0.027	517|10	52|0	0.01458	676|10	9	139407552	139407552	C	T	contamination	NOTCH1	NM_017617.5	15	c.2388G>A	p.Ala796=	synonymous_variant	Benign/Likely_benign		Adams-Oliver_syndrome_5|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Aortic_valve_disease_1|not_provided		
	SKIDA1(8.5%)	exon4,c.1269_1272delinsAGAGGAG,p.E424dup	0.085	0.075	76|6	9|0	0.55833	106|134	10	21805480	21805483	TTCC	CTCCTCT	clustered_events,contamination,haplotype,background	SKIDA1	NM_207371.4	4	c.1269_1272delinsAGAGGAG	p.Glu424dup	disruptive_inframe_insertion&synonymous_variant				COSV71610443	
1	RET(0.1%)	exon11,c.1900T>C,p.C634R	0.00114	0.001503	4730|5	1571|1	0.00045	15566|7	10	43609948	43609948	T	C	clustered_events,weak_evidence	RET	NM_020975.6	11	c.1900T>C	p.Cys634Arg	missense_variant	Pathogenic		Pheochromocytoma|Medullary_thyroid_carcinoma|Thyroid_gland_carcinoma|Multiple_endocrine_neoplasia,_type_1|Multiple_endocrine_neoplasia,_type_2b|Multiple_endocrine_neoplasia,_type_2a|Multiple_endocrine_neoplasia_type_4|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|not_provided		
-	PTEN(1.5%)	exon8,c.802-5_802-3del	0.015	0.004439	698|19	122|0	0.00950	1980|19	10	89720633	89720636	CTTT	C	clustered_events,multiallelic,normal_artifact	PTEN	NM_000314.8	8	c.802-5_802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome		
-	PTEN(3.8%)	exon8,c.802-4_802-3del	0.038	0.019	698|62	122|7	0.05308	1980|111	10	89720633	89720636	CTTT	CT	clustered_events,multiallelic,normal_artifact	PTEN	NM_000314.8	8	c.802-4_802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	PTEN(10.0%)	exon8,c.802-3dup	0.1	0.089	698|143	122|24	0.12698	1980|288	10	89720633	89720636	CTTT	CTTTT	clustered_events,multiallelic,normal_artifact,suspected_bg	PTEN	NM_000314.8	8	c.802-3dup		splice_acceptor_variant&intron_variant	Benign		Malignant_tumor_of_prostate|Cowden_syndrome_1|Macrocephaly-autism_syndrome|Familial_meningioma|Glioma_susceptibility_2|Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome|not_specified|not_provided		
-	PTEN(2.9%)	exon8,c.802-2A>T	0.029	0.067	1486|53	285|25	0.09995	3485|387	10	89720649	89720649	A	T	clustered_events,multiallelic,normal_artifact,orientation,background	PTEN	NM_000314.8	8	c.802-2A>T		splice_acceptor_variant&intron_variant	Pathogenic		Cowden_syndrome_1|Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome|not_provided		
-	PTEN(0.4%)	exon8,c.802-2A>G	0.003518	0.003326	1486|9	285|0	0.00343	3485|12	10	89720649	89720649	A	G	clustered_events,multiallelic,normal_artifact,orientation,background,low_allele_frac	PTEN	NM_000314.8	8	c.802-2A>G		splice_acceptor_variant&intron_variant	Pathogenic		Cowden_syndrome_1|Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome		
	FGFR2(2.0%)	exon5,c.549del,p.N184fs	0.02	0.013	432|8	103|0	0.01508	588|9	10	123310878	123310879	TC	T	background	FGFR2	NM_000141.5	5	c.549del	p.Asn184fs	frameshift_variant					
-	WT1(1.4%)	exon10,c.1473G>A,p.W491*	0.014	0.00731	458|6	185|0	0.00935	636|6	11	32410700	32410700	C	T	suspected_bg,chemotherapy_site	WT1	NM_024426.6	10	c.1473G>A	p.Trp491*	stop_gained					
	GSTP1(1.5%)	exon6,c.387T>C,p.P129=	0.015	0.005519	570|7	228|0	0.01080	916|10	11	67353625	67353625	T	C	background,chemotherapy_site	GSTP1	NM_000852.4	6	c.387T>C	p.Pro129=	synonymous_variant					
	CCND1(2.5%)	exon4,c.614C>T,p.A205V	0.025	0.029	328|6	94|2	0.01878	418|8	11	69462801	69462801	C	T	normal_artifact,distinguished	CCND1	NM_053056.3	4	c.614C>T	p.Ala205Val	missense_variant				COSV99919817	
	EMSY(1.2%)	exon5,c.338C>T,p.T113I	0.012	0.00824	492|5	157|0	0.01173	674|8	11	76169319	76169319	C	T	PASS	EMSY	NM_020193.5	5	c.338C>T	p.Thr113Ile	missense_variant					
	MRE11(1.8%)	exon9,c.945T>C,p.A315=	0.018	0.012	341|5	109|0	0.01149	430|5	11	94203709	94203709	A	G	PASS	MRE11	NM_005591.4	9	c.945T>C	p.Ala315=	synonymous_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome		
-	ATM(2.2%)	exon6,c.497-5_497-4del	0.022	0.035	272|8	110|5	0.01856	476|9	11	108114661	108114663	ATT	A	multiallelic,normal_artifact	ATM	NM_000051.4	6	c.497-5_497-4del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome		
-	ATM(18.2%)	exon6,c.497-4del	0.182	0.159	272|77	110|24	0.19865	476|118	11	108114661	108114663	ATT	AT	multiallelic,normal_artifact,suspected_bg	ATM	NM_000051.4	6	c.497-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_specified|not_provided		
-	ATM(12.7%)	exon6,c.497-4dup	0.127	0.103	272|55	110|16	0.14079	476|78	11	108114661	108114663	ATT	ATTT	multiallelic,normal_artifact,suspected_bg	ATM	NM_000051.4	6	c.497-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	ATM(10.0%)	exon10,c.1236-4_1236-3del	0.1	0.035	209|41	45|3	0.09899	446|49	11	108121410	108121412	CTT	C	clustered_events,multiallelic,normal_artifact,slippage	ATM	NM_000051.4	10	c.1236-4_1236-3del		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided		
-	ATM(3.9%)	exon10,c.1236-2A>T	0.039	0.033	388|16	111|4	0.07133	703|54	11	108121426	108121426	A	T	base_qual,clustered_events,contamination,haplotype,normal_artifact,orientation,strand_bias,background	ATM	NM_000051.4	10	c.1236-2A>T		splice_acceptor_variant&intron_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(2)|Uncertain_significance(1)	Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome		
	CD3G(3.1%)	exon3,c.213del,p.K71fs	0.031	0.045	2195|83	658|36	0.03355	4638|161	11	118220582	118220583	TA	T	contamination,multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|Likely_pathogenic(1)|Uncertain_significance(1)	Severe_combined_immunodeficiency_disease|Combined_immunodeficiency_due_to_CD3gamma_deficiency		
	CD3G(1.2%)	exon3,c.213dup,p.W72fs	0.012	0.026	2195|48	658|20	0.01862	4638|88	11	118220582	118220583	TA	TAA	contamination,multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic/Likely_pathogenic		Severe_combined_immunodeficiency_disease|Combined_immunodeficiency_due_to_CD3gamma_deficiency		
	KMT2A(1.0%)	exon3,c.2318del,p.P773fs	0.01	0.00856	4985|105	1409|15	0.01091	14781|163	11	118344185	118344186	AC	A	normal_artifact,background	KMT2A	NM_001197104.2	3	c.2318del	p.Pro773fs	frameshift_variant	Pathogenic		Wiedemann-Steiner_syndrome|Inborn_genetic_diseases		
2	KMT2A(1.9%)	exon4,c.3157-2A>G	0.019	0.012	304|6	99|0	0.01523	388|6	11	118347518	118347518	A	G	PASS	KMT2A	NM_001197104.2	4	c.3157-2A>G		splice_acceptor_variant&intron_variant					
	KDM5A(0.9%)	exon26,c.4269C>T,p.S1423=	0.009209	0.021	675|6	124|1	0.00665	896|6	12	404925	404925	G	A	normal_artifact	KDM5A	NM_001042603.3	26	c.4269C>T	p.Ser1423=	synonymous_variant					
	KDM5A(0.7%)	exon23,c.3636C>T,p.C1212=	0.007445	0.005258	1207|9	252|0	0.00529	1692|9	12	416914	416914	G	A	low_allele_frac	KDM5A	NM_001042603.3	23	c.3636C>T	p.Cys1212=	synonymous_variant					
	CHD4(1.1%)	exon33,c.4796C>T,p.A1599V	0.011	0.025	697|6	101|1	0.01089	908|10	12	6690323	6690323	G	A	haplotype,normal_artifact	CHD4	NM_001273.5	33	c.4796C>T	p.Ala1599Val	missense_variant					
	CHD4(0.8%)	exon17,c.2578G>A,p.A860T	0.008017	0.009596	987|8	153|0	0.00873	1363|12	12	6702331	6702331	C	T	PASS	CHD4	NM_001273.5	17	c.2578G>A	p.Ala860Thr	missense_variant					
	CHD4(1.1%)	exon13,c.1908C>T,p.G636=	0.011	0.017	536|5	83|0	0.00943	735|7	12	6705288	6705288	G	A	PASS	CHD4	NM_001273.5	13	c.1908C>T	p.Gly636=	synonymous_variant					
	CHD4(7.5%)	exon4,c.417_419del,p.E139del	0.075	0.111	130|8	7|0	0.06923	121|9	12	6711144	6711147	ATCC	A	clustered_events,contamination,slippage,suspected_bg	CHD4	NM_001273.5	4	c.417_419del	p.Glu139del	disruptive_inframe_deletion	Uncertain_significance		not_provided		
	CHD4(32.2%)	exon4,c.417G>T,p.E139D	0.322	0.333	108|44	7|2	0.33516	121|61	12	6711147	6711147	C	A	clustered_events,germline,normal_artifact,Germline	CHD4	NM_001273.5	4	c.417G>T	p.Glu139Asp	missense_variant	Benign		Sifrim-Hitz-Weiss_syndrome|not_provided		
	CHD4(3.2%)	exon4,c.406G>A,p.E136K	0.032	0.125	142|4	7|0	0.02312	169|4	12	6711158	6711158	C	T	clustered_events	CHD4	NM_001273.5	4	c.406G>A	p.Glu136Lys	missense_variant					
	CHD4(8.2%)	exon2,c.8C>T,p.S3L	0.082	0.12	47|4	7|0	0.08955	61|6	12	6715532	6715532	G	A	orientation	CHD4	NM_001273.5	2	c.8C>T	p.Ser3Leu	missense_variant					
1	KRAS(0.1%)	exon4,c.437C>T,p.A146V	0.0008469	0.0005404	9409|7	4178|1	0.00071	56198|40	12	25378561	25378561	G	A	weak_evidence	KRAS	NM_033360.4	4	c.437C>T	p.Ala146Val	missense_variant	Pathogenic		OCULOECTODERMAL_SYNDROME,_SOMATIC|Non-small_cell_lung_carcinoma|Thyroid_tumor|Neoplasm_of_the_large_intestine|Encephalocraniocutaneous_lipomatosis		
1	KRAS(0.2%)	exon3,c.175G>A,p.A59T	0.001602	0.001834	7771|12	2949|6	0.00097	36002|35	12	25380283	25380283	C	T	clustered_events,normal_artifact	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic		
1	KRAS(0.1%)	exon2,c.38G>A,p.G13D	0.001274	0.0009422	8682|11	3794|2	0.00121	42902|52	12	25398281	25398281	C	T	clustered_events,weak_evidence	KRAS	NM_033360.4	2	c.38G>A	p.Gly13Asp	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(5)|Uncertain_significance(1)	OCULOECTODERMAL_SYNDROME,_SOMATIC|Acute_myeloid_leukemia|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Thyroid_tumor|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Breast_adenocarcinoma|Encephalocraniocutaneous_lipomatosis|Autoimmune_lymphoproliferative_syndrome_type_4|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|Inborn_genetic_diseases|not_provided		
1	KRAS(0.1%)	exon2,c.34G>A,p.G12S	0.00109	0.0009202	8676|10	3777|2	0.00083	43285|36	12	25398285	25398285	C	T	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Gastric_cancer|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Thyroid_tumor|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|RASopathy|not_provided		
	ARID2(1.3%)	exon15,c.3140C>T,p.A1047V	0.013	0.018	582|8	141|1	0.00928	854|8	12	46245046	46245046	C	T	normal_artifact	ARID2	NM_152641.4	15	c.3140C>T	p.Ala1047Val	missense_variant					
	ARID2(1.7%)	exon15,c.3813C>T,p.C1271=	0.017	0.009688	699|13	131|0	0.01577	936|15	12	46245719	46245719	C	T	PASS	ARID2	NM_152641.4	15	c.3813C>T	p.Cys1271=	synonymous_variant					
	KMT2D(4.2%)	exon45,c.14097C>T,p.S4699=	0.042	0.031	188|6	39|0	0.02703	216|6	12	49422998	49422998	G	A	PASS	KMT2D	NM_003482.4	45	c.14097C>T	p.Ser4699=	synonymous_variant	Likely_benign		Kabuki_syndrome		
-	KMT2D(1.5%)	exon32,c.7199del,p.P2400fs	0.015	0.048	503|9	66|2	0.01472	937|14	12	49434353	49434354	AG	A	normal_artifact	KMT2D	NM_003482.4	32	c.7199del	p.Pro2400fs	frameshift_variant					
	KMT2D(0.2%)	exon11,c.2463_2543del,p.P822_E848del	0.001957	0.001797	4130|8	688|0	0.00000	220|0	12	49444922	49445003	TTCCTCAGGCCGGGGGGACAGGCATGGCTCCTCAGACTGGGGGGACAGGTGTGATTCCTCAGGTTGGGGGGACAAGCATGGC	T	low_allele_frac	KMT2D	NM_003482.4	11	c.2463_2543del	p.Pro822_Glu848del	disruptive_inframe_deletion					
	ERBB3(10.0%)	exon20,c.2413G>A,p.A805T	0.1	0.112	52|4	9|0	0.06154	61|4	12	56490967	56490967	G	A	PASS	ERBB3	NM_001982.4	20	c.2413G>A	p.Ala805Thr	missense_variant					
	MDM2(0.9%)	exon11,c.1438C>T,p.P480S	0.008937	0.007584	653|6	176|0	0.00686	869|6	12	69233573	69233573	C	T	PASS	MDM2	NM_002392.5	11	c.1438C>T	p.Pro480Ser	missense_variant					
	FRS2(1.4%)	exon10,c.1394C>T,p.T465I	0.014	0.015	305|4	80|0	0.01044	379|4	12	69968602	69968602	C	T	PASS	FRS2	NM_006654.5	10	c.1394C>T	p.Thr465Ile	missense_variant					
	FLT1(1.8%)	exon19,c.2599G>A,p.A867T	0.018	0.052	346|6	52|1	0.01361	435|6	13	28903860	28903860	C	T	normal_artifact,distinguished	FLT1	NM_002019.4	19	c.2599G>A	p.Ala867Thr	missense_variant				COSV56729828	
-	BRCA2(1.5%)	exon10,c.1813del,p.I605fs	0.015	0.017	3921|74	1071|24	0.01850	10026|189	13	32907420	32907421	GA	G	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	10	c.1813del	p.Ile605fs	frameshift_variant	Pathogenic		Hereditary_breast_ovarian_cancer_syndrome|Fanconi_anemia_complementation_group_D1|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided		
-	BRCA2(0.6%)	exon10,c.1813dup,p.I605fs	0.006403	0.003328	3921|38	1071|6	0.00792	10026|80	13	32907420	32907421	GA	GAA	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg,low_allele_frac	BRCA2	NM_000059.4	10	c.1813dup	p.Ile605fs	frameshift_variant	Pathogenic		Breast_carcinoma|Hereditary_breast_ovarian_cancer_syndrome|Carcinoma_of_pancreas|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|BRCA2-Related_Disorders|not_provided		
-	BRCA2(0.9%)	exon11,c.5073del,p.K1691fs	0.008526	0.014	3446|42	845|12	0.01190	6973|84	13	32913558	32913559	CA	C	normal_artifact,suspected_bg	BRCA2	NM_000059.4	11	c.5073del	p.Lys1691fs	frameshift_variant	Pathogenic		Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome|not_provided		
-	BRCA2(1.8%)	exon23,c.9097dup,p.T3033fs	0.018	0.016	2908|58	883|15	0.01548	6424|101	13	32954022	32954022	C	CA	contamination,normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Breast_carcinoma|Neoplasm_of_ovary|Hereditary_breast_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided		
	BRCA2(0.2%)	exon25,c.9304G>A,p.A3102T	0.002029	0.0005725	8100|17	2380|0	0.00219	27307|60	13	32968873	32968873	G	A	low_allele_frac	BRCA2	NM_000059.4	25	c.9304G>A	p.Ala3102Thr	missense_variant	Uncertain_significance		Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome		
	NBEA(0.5%)	exon22,c.3362dup,p.N1121fs	0.004586	0.003059	6129|43	1590|10	0.00784	16198|128	13	35733662	35733662	T	TA	slippage,weak_evidence,suspected_bg,low_allele_frac	NBEA	NM_015678.5	22	c.3362dup	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy		
-	RB1(2.6%)	exon7,c.608-4del	0.026	0.025	8747|310	3437|111	0.02793	54987|1580	13	48934140	48934141	AT	A	contamination,multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	7	c.608-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	RB1(1.9%)	exon7,c.608-4dup	0.019	0.026	8747|242	3437|122	0.03083	54987|1749	13	48934140	48934141	AT	ATT	contamination,multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	7	c.608-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome		
	DICER1(0.8%)	exon23,c.4450C>T,p.P1484S	0.008407	0.006892	1157|10	353|1	0.00529	1882|10	14	95562807	95562807	G	A	PASS	DICER1	NM_177438.3	23	c.4450C>T	p.Pro1484Ser	missense_variant					
	DICER1(0.9%)	exon12,c.2040+1G>A	0.009305	0.004589	722|7	263|0	0.00935	1165|11	14	95579428	95579428	C	T	PASS	DICER1	NM_177438.3	12	c.2040+1G>A		splice_donor_variant&intron_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome		
	HSP90AA1(1.4%)	exon11,c.2165T>C,p.V722A	0.014	0.017	329|4	83|0	0.00971	408|4	14	102548738	102548738	A	G	PASS	HSP90AA1	NM_001017963.3	11	c.2165T>C	p.Val722Ala	missense_variant					
	NTRK3(63.8%)	exon7,c.573C>T,p.N191=	0.638	0.6	4|10	1|2	0.71429	4|10	15	88680684	88680684	G	A	germline,normal_artifact,Germline	NTRK3	NM_001012338.3	7	c.573C>T	p.Asn191=	synonymous_variant	Benign		not_provided		
	IDH2(0.4%)	exon4,c.435G>A,p.G145=	0.003942	0.002281	1908|6	588|0	0.01031	3936|41	15	90631918	90631918	C	T	low_allele_frac	IDH2	NM_002168.4	4	c.435G>A	p.Gly145=	synonymous_variant					
	BLM(2.3%)	exon7,c.1544del,p.N515fs	0.023	0.016	7462|231	4363|90	0.02616	53336|1433	15	91304138	91304139	GA	G	multiallelic,normal_artifact,suspected_bg	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome|Hereditary_cancer-predisposing_syndrome		
	BLM(0.9%)	exon7,c.1544dup,p.N515fs	0.009386	0.019	7462|114	4363|102	0.02209	53336|1205	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,suspected_bg	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome		
	CHD2(4.2%)	exon3,c.71C>T,p.A24V	0.042	0.03	146|6	41|0	0.03409	170|6	15	93467559	93467559	C	T	PASS	CHD2	NM_001271.4	3	c.71C>T	p.Ala24Val	missense_variant					
	CHD2(2.5%)	exon29,c.3734del,p.K1245fs	0.025	0.044	793|21	212|11	0.02391	1143|28	15	93540315	93540317	GAA	GA	contamination,multiallelic,normal_artifact,suspected_bg	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(3)|Likely_pathogenic(1)|Uncertain_significance(1)	Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_specified|not_provided		
	CHD2(2.9%)	exon34,c.4413+2del	0.029	0.025	150|4	58|0	0.02128	184|4	15	93547982	93547983	GT	G	PASS	CHD2	NM_001271.4	34	c.4413+2del		splice_donor_variant&intron_variant					
	CREBBP(80.0%)	exon31,c.6711C>T,p.P2237=	0.8	0.5	0|4	0|0	1.00000	0|4	16	3778337	3778337	G	A	germline	CREBBP	NM_004380.3	31	c.6711C>T	p.Pro2237=	synonymous_variant	Benign		Rubinstein-Taybi_syndrome|Inborn_genetic_diseases|not_specified|not_provided		
	GRIN2A(2.0%)	exon13,c.2903C>T,p.A968V	0.02	0.013	372|5	94|0	0.01258	471|6	16	9858498	9858498	G	A	distinguished	GRIN2A	NM_001134407.3	13	c.2903C>T	p.Ala968Val	missense_variant					
	PALB2(0.6%)	exon4,c.886del,p.M296*	0.00637	0.00489	4094|35	1407|9	0.00787	14370|114	16	23646980	23646981	AT	A	normal_artifact,suspected_bg,low_allele_frac	PALB2	NM_024675.4	4	c.886del	p.Met296*	frameshift_variant&stop_gained	Pathogenic		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided		
	PRSS8(0.6%)	exon5,c.642G>A,p.P214=	0.005937	0.001941	4135|24	761|1	0.00429	10687|46	16	31143813	31143813	C	T	background,low_allele_frac	PRSS8	NM_002773.5	5	c.642G>A	p.Pro214=	synonymous_variant				COSV54898066	
2	NUP93(0.8%)	exon20,c.2137-18G>A	0.008279	0.007299	925|9	161|0	0.00826	1440|12	16	56873415	56873415	G	A	PASS	NUP93	NM_014669.5	20	c.2137-18G>A		intron_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|Uncertain_significance(1)	not_provided		
-	CDH1(0.8%)	exon3,c.377del,p.P126fs	0.008056	0.008148	8380|137	2795|36	0.00821	38882|322	16	68835780	68835781	GC	G	clustered_events,normal_artifact	CDH1	NM_004360.5	3	c.377del	p.Pro126fs	frameshift_variant	Pathogenic		Hereditary_diffuse_gastric_adenocarcinoma|Hereditary_cancer-predisposing_syndrome|not_provided		
	PLCG2(94.7%)	exon16,c.1497C>T,p.A499=	0.947	0.667	0|27	0|1	1.00000	0|33	16	81941319	81941319	C	T	germline,normal_artifact,Germline	PLCG2	NM_002661.5	16	c.1497C>T	p.Ala499=	synonymous_variant	Benign		Familial_cold_autoinflammatory_syndrome_3|Autoinflammation-PLCG2-associated_antibody_deficiency-immune_dysregulation|not_specified|not_provided		
	PLCG2(94.3%)	exon28,c.3093T>C,p.N1031=	0.943	0.286	1|46	6|2	0.97872	1|46	16	81971403	81971403	T	C	germline,normal_artifact,Germline	PLCG2	NM_002661.5	28	c.3093T>C	p.Asn1031=	synonymous_variant	Benign		Familial_cold_autoinflammatory_syndrome_3|Autoinflammation-PLCG2-associated_antibody_deficiency-immune_dysregulation|not_specified|not_provided		
	FANCA(1.6%)	exon42,c.4169G>A,p.G1390D	0.016	0.02	607|7	59|0	0.01178	755|9	16	89805381	89805381	C	T	PASS	FANCA	NM_000135.4	42	c.4169G>A	p.Gly1390Asp	missense_variant&splice_region_variant					
	FANCA(4.5%)	exon23,c.2023G>A,p.A675T	0.045	0.053	129|4	28|0	0.02614	149|4	16	89838214	89838214	C	T	orientation	FANCA	NM_000135.4	23	c.2023G>A	p.Ala675Thr	missense_variant	Uncertain_significance		Fanconi_anemia		
	FANCA(3.6%)	exon11,c.898G>A,p.G300R	0.036	0.037	146|4	31|0	0.02041	192|4	16	89862422	89862422	C	T	orientation	FANCA	NM_000135.4	11	c.898G>A	p.Gly300Arg	missense_variant	Uncertain_significance		Fanconi_anemia_complementation_group_A		
	FANCA(1.4%)	exon9,c.820C>T,p.L274=	0.014	0.038	463|4	72|1	0.00887	559|5	16	89866019	89866019	G	A	haplotype,normal_artifact,orientation	FANCA	NM_000135.4	9	c.820C>T	p.Leu274=	synonymous_variant	Pathogenic		Fanconi_anemia_complementation_group_A		
	TP53(74.8%)	exon7,c.742C>T,p.R248W	0.748	0.003794	250|748	356|0	0.72537	460|1215	17	7577539	7577539	G	A	PASS	TP53	NM_000546.6	7	c.742C>T	p.Arg248Trp	missense_variant	Pathogenic		Li-Fraumeni_syndrome_1|Abnormality_of_the_tongue|Webbed_neck|Pectus_excavatum|Hepatocellular_carcinoma|Short_stature|Pancytopenia|Acute_myeloid_leukemia|Cognitive_impairment|Neoplasm|Medulloblastoma|B-cell_chronic_lymphocytic_leukemia|Pancreatic_adenocarcinoma|Squamous_cell_carcinoma_of_the_skin|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Choroid_plexus_carcinoma|Neoplasm_of_brain|Gastric_adenocarcinoma|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Prostate_adenocarcinoma|Gallbladder_cancer|Ovarian_serous_cystadenocarcinoma|Uterine_carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Hereditary_cancer-predisposing_syndrome|Glioblastoma|Li-Fraumeni_syndrome|Myelodysplastic_syndrome|Lip_and_oral_cavity_carcinoma|Malignant_neoplasm_of_body_of_uterus|not_provided		
	TP53(5.2%)	exon5,c.455C>T,p.P152L	0.052	0.001138	2788|154	1082|0	0.05684	7202|434	17	7578475	7578475	G	A	PASS	TP53	NM_000546.6	5	c.455C>T	p.Pro152Leu	missense_variant	Pathogenic		Li-Fraumeni_syndrome_1|Squamous_cell_carcinoma_of_the_head_and_neck|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Li-Fraumeni_syndrome|Lip_and_oral_cavity_carcinoma|not_provided		
-	NF1(2.2%)	exon2,c.61-4del	0.022	0.034	947|30	239|10	0.02191	1518|34	17	29482988	29482989	CT	C	contamination,normal_artifact,slippage,suspected_bg	NF1	NM_000267.3	2	c.61-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Neurofibromatosis,_familial_spinal|Caf??-au-lait_macules_with_pulmonary_stenosis|Neurofibromatosis-Noonan_syndrome|Hereditary_cancer-predisposing_syndrome|Neurofibromatosis,_type_1|not_specified|Cardiovascular_phenotype|not_provided		
-	NF1(1.5%)	exon18,c.2033del,p.P678fs	0.015	0.013	2131|37	471|7	0.01672	4646|79	17	29553477	29553478	AC	A	haplotype,normal_artifact,background	NF1	NM_000267.3	18	c.2033del	p.Pro678fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|Neurofibromatosis,_type_1|not_provided		
	NF1(0.8%)	exon18,c.2069C>T,p.A690V	0.008011	0.002543	2634|21	612|0	0.00569	5766|33	17	29553520	29553520	C	T	PASS	NF1	NM_000267.3	18	c.2069C>T	p.Ala690Val	missense_variant	Uncertain_significance		Neurofibromatosis,_type_1		
	CDK12(3.2%)	exon1,c.132G>A,p.R44=	0.032	0.016	221|6	81|0	0.02041	288|6	17	37618456	37618456	G	A	distinguished	CDK12	NM_016507.4	1	c.132G>A	p.Arg44=	synonymous_variant					
	ERBB2(0.7%)	exon10,c.1202A>T,p.E401V	0.00685	0.003182	1127|8	417|0	0.00439	2039|9	17	37871592	37871592	A	T	low_allele_frac	ERBB2	NM_004448.4	10	c.1202A>T	p.Glu401Val	missense_variant					
	TOP2A(2.2%)	exon12,c.1406C>T,p.A469V	0.022	0.016	336|6	78|0	0.01408	420|6	17	38564313	38564313	G	A	PASS	TOP2A	NM_001067.4	12	c.1406C>T	p.Ala469Val	missense_variant					
	KRTAP4-11(8.3%)	exon1,c.257_361del,p.K86_C120del	0.083	0.049	200|15	52|3	0.04545	21|1	17	39274206	39274311	CTGCAGCAGCTGGACACACAGCAGCTGGGGCGACAGCAGCTGGAGATGCAGCATCTGGGGCGGCAGCAAGTGGGCTGGCAGCACATAGACTGGCAGCACTGGGGCT	C	contamination,normal_artifact	KRTAP4-11	NM_033059.4	1	c.257_361del	p.Lys86_Cys120del	disruptive_inframe_deletion					
	XYLT2(1.1%)	exon8,c.1584del,p.G529fs	0.011	0.009606	1526|35	488|6	0.01087	3002|33	17	48433966	48433967	AC	A	clustered_events,contamination,suspected_bg	XYLT2	NM_022167.4	8	c.1584del	p.Gly529fs	frameshift_variant	Likely_pathogenic		Spondylo-ocular_syndrome		
	BRIP1(1.0%)	exon3,c.189G>A,p.W63*	0.009745	0.007159	652|6	197|0	0.00658	906|6	17	59937173	59937173	C	T	background	BRIP1	NM_032043.3	3	c.189G>A	p.Trp63*	stop_gained	Pathogenic		Fanconi_anemia_complementation_group_J|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast		
	ABCA6(5.9%)	exon19,c.2428del,p.L810fs	0.059	0.001144	2849|182	1198|0	0.05769	7138|437	17	67102313	67102314	AG	A	PASS	ABCA6	NM_080284.3	19	c.2428del	p.Leu810fs	frameshift_variant					
	RPTOR(88.9%)	exon22,c.2526C>T,p.T842=	0.889	0.667	0|11	0|2	1.00000	0|12	17	78896529	78896529	C	T	germline,normal_artifact,Germline	RPTOR	NM_020761.3	22	c.2526C>T	p.Thr842=	synonymous_variant				COSV60802444	
	RPTOR(8.5%)	exon24,c.2865G>A,p.V955=	0.085	0.048	47|4	23|0	0.06897	54|4	17	78899226	78899226	G	A	PASS	RPTOR	NM_020761.3	24	c.2865G>A	p.Val955=	synonymous_variant					
	RPTOR(91.7%)	exon27,c.3231C>T,p.N1077=	0.917	0.667	0|15	0|1	1.00000	0|17	17	78921117	78921117	C	T	germline,normal_artifact,Germline	RPTOR	NM_020761.3	27	c.3231C>T	p.Asn1077=	synonymous_variant				COSV60802469	
	RPTOR(2.2%)	exon31,c.3650C>T,p.A1217V	0.022	0.018	327|5	70|0	0.01176	420|5	17	78935238	78935238	C	T	PASS	RPTOR	NM_020761.3	31	c.3650C>T	p.Ala1217Val	missense_variant					
	TXNDC2(7.6%)	exon2,c.750G>A,p.K250=	0.076	0.038	75|7	25|0	0.08494	237|22	18	9887226	9887226	G	A	orientation,background	TXNDC2	NM_001098529.2	2	c.750G>A	p.Lys250=	synonymous_variant				COSV60152793	
	TXNDC2(8.4%)	exon2,c.1013_1017delinsCACCC,p.Q338P	0.084	0.042	129|8	27|0	0.01562	252|4	18	9887489	9887493	AGCCT	CACCC	clustered_events,haplotype	TXNDC2	NM_001098529.2	2	c.1013_1017delinsCACCC	p.Gln338Pro	missense_variant					
	SETBP1(1.2%)	exon4,c.2630G>A,p.S877N	0.012	0.008861	506|6	154|0	0.00823	723|6	18	42531935	42531935	G	A	PASS	SETBP1	NM_015559.3	4	c.2630G>A	p.Ser877Asn	missense_variant					
	SMAD4(71.0%)	exon9,c.1048G>T,p.V350F	0.71	0.0005702	846|2114	2420|3	0.70864	3401|8272	18	48591885	48591885	G	T	PASS	SMAD4	NM_005359.6	9	c.1048G>T	p.Val350Phe	missense_variant				COSV61688949	
	GNA11(83.3%)	exon6,c.771C>T,p.T257=	0.833	0.571	5|31	4|3	0.86842	5|33	19	3119239	3119239	C	T	germline,normal_artifact,Germline	GNA11	NM_002067.5	6	c.771C>T	p.Thr257=	synonymous_variant	Benign		not_specified|not_provided		
	MAP2K2(53.3%)	exon6,c.619G>A,p.E207K	0.533	0.5	10|10	0|0	0.54545	10|12	19	4101103	4101103	C	T	PASS	MAP2K2	NM_030662.4	6	c.619G>A	p.Glu207Lys	missense_variant	Likely_pathogenic		Cardio-facio-cutaneous_syndrome|Noonan_syndrome|RASopathy|not_provided		
	KEAP1(0.8%)	exon4,c.1437C>T,p.D479=	0.007632	0.00297	2315|18	415|0	0.00528	3955|21	19	10600418	10600418	G	A	background,low_allele_frac	KEAP1	NM_203500.2	4	c.1437C>T	p.Asp479=	synonymous_variant				COSV50658648	
	PIK3R2(83.3%)	exon15,c.1911T>C,p.S637=	0.833	0.5	0|6	0|0	1.00000	0|6	19	18279638	18279638	T	C	germline	PIK3R2	NM_005027.4	15	c.1911T>C	p.Ser637=	synonymous_variant	Benign		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus_syndrome_1|not_specified|not_provided		
	CCNE1(1.8%)	exon5,c.312G>A,p.P104=	0.018	0.012	347|6	99|0	0.01418	417|6	19	30308175	30308175	G	A	PASS	CCNE1	NM_001238.4	5	c.312G>A	p.Pro104=	synonymous_variant					
	HNRNPL(12.4%)	exon8,c.1010del,p.P337fs	0.124	0.117	29|4	5|0	0.10526	34|4	19	39330958	39330959	TG	T	slippage,suspected_bg	HNRNPL	NM_001533.3	8	c.1010del	p.Pro337fs	frameshift_variant					
	AXL(87.4%)	exon7,c.796A>G,p.N266D	0.874	0.667	0|10	0|2	1.00000	0|13	19	41743861	41743861	A	G	germline,normal_artifact,Germline	AXL	NM_021913.5	7	c.796A>G	p.Asn266Asp	missense_variant	Benign		not_provided		
	XRCC1(3.2%)	exon10,c.1172G>A,p.R391H	0.032	0.029	183|5	42|0	0.03167	214|7	19	44055750	44055750	C	T	haplotype,distinguished,chemotherapy_site	XRCC1	NM_006297.3	10	c.1172G>A	p.Arg391His	missense_variant					
	POLR1G(3.0%)	exon3,c.1523_1525del,p.Q508del	0.03	0.009896	467|14	129|0	0.02613	708|19	19	45912733	45912736	AAGC	A	contamination,slippage,suspected_bg	POLR1G	NM_012099.3	3	c.1523_1525del	p.Gln508del	disruptive_inframe_deletion					
	BAX(2.8%)	exon3,c.121del,p.E41fs	0.028	0.016	1226|44	404|6	0.02834	2537|74	19	49458970	49458971	TG	T	contamination,normal_artifact,slippage,suspected_bg	BAX	NM_138761.4	3	c.121del	p.Glu41fs	frameshift_variant	Pathogenic		Carcinoma_of_colon		
	ASXL1(0.9%)	exon5,c.260C>T,p.A87V	0.008776	0.009168	1872|18	289|2	0.00686	2896|20	20	31015938	31015938	C	T	background	ASXL1	NM_015338.6	5	c.260C>T	p.Ala87Val	missense_variant				COSV60120545	
	ASXL1(1.4%)	exon13,c.3612C>T,p.C1204=	0.014	0.017	514|6	74|0	0.00923	644|6	20	31024127	31024127	C	T	PASS	ASXL1	NM_015338.6	13	c.3612C>T	p.Cys1204=	synonymous_variant					
	SRC(94.1%)	exon12,c.1218G>C,p.A406=	0.941	0.5	0|26	0|0	1.00000	0|30	20	36030939	36030939	G	C	germline	SRC	NM_198291.3	12	c.1218G>C	p.Ala406=	synonymous_variant				COSV62440282	
	ARFRP1(35.8%)	exon7,c.483A>C,p.R161=	0.358	0.428	68|37	5|2	0.35246	79|43	20	62331989	62331989	T	G	germline,normal_artifact,Germline	ARFRP1	NM_001267547.3	7	c.483A>C	p.Arg161=	synonymous_variant				COSV53926154	
	KRTAP10-6(70.8%)	exon1,c.126T>C,p.C42=	0.708	0.6	10|25	1|2	0.75610	10|31	21	46012240	46012240	A	G	clustered_events,germline,normal_artifact,Germline	KRTAP10-6	NM_198688.3	1	c.126T>C	p.Cys42=	synonymous_variant				COSV59957290	
	SLC19A1(36.2%)	exon2,c.80A>G,p.H27R	0.362	0.518	43|22	2|3	0.30667	52|23	21	46957794	46957794	T	C	germline,normal_artifact,Germline	SLC19A1	NM_194255.4	2	c.80A>G	p.His27Arg	missense_variant	drug_response		Gastrointestinal_stromal_tumor|methotrexate_response_-_Efficacy|not_provided		
	BCR(1.6%)	exon19,c.3283G>A,p.A1095T	0.016	0.022	351|5	105|2	0.01040	476|5	22	23653984	23653984	G	A	PASS	BCR	NM_004327.4	19	c.3283G>A	p.Ala1095Thr	missense_variant					
	SMARCB1(2.3%)	exon6,c.703C>T,p.P235S	0.023	0.026	199|4	48|0	0.01521	259|4	22	24159031	24159031	C	T	PASS	SMARCB1	NM_003073.5	6	c.703C>T	p.Pro235Ser	missense_variant				COSV105838422	
	NF2(1.5%)	exon5,c.509C>T,p.P170L	0.015	0.021	318|4	67|0	0.00995	398|4	22	30050707	30050707	C	T	PASS	NF2	NM_000268.4	5	c.509C>T	p.Pro170Leu	missense_variant	Uncertain_significance		Neurofibromatosis,_type_2		
	EP300(1.6%)	exon5,c.1251C>T,p.L417=	0.016	0.018	294|4	81|1	0.01609	367|6	22	41525976	41525976	C	T	PASS	EP300	NM_001429.4	5	c.1251C>T	p.Leu417=	synonymous_variant					
	EP300(0.7%)	exon8,c.1664C>A,p.P555H	0.007317	0.018	605|4	149|3	0.01104	806|9	22	41533698	41533698	C	A	normal_artifact,low_allele_frac	EP300	NM_001429.4	8	c.1664C>A	p.Pro555His	missense_variant					
	EP300(1.7%)	exon9,c.1803A>G,p.K601=	0.017	0.02	566|8	143|1	0.01084	821|9	22	41536186	41536186	A	G	normal_artifact	EP300	NM_001429.4	9	c.1803A>G	p.Lys601=	synonymous_variant					
	BCOR(1.2%)	exon13,c.4787G>A,p.G1596D	0.012	0.021	635|7	66|0	0.00815	852|7	X	39913541	39913541	C	T	PASS	BCOR	NM_001123385.2	13	c.4787G>A	p.Gly1596Asp	missense_variant					
	BCOR(2.1%)	exon6,c.3064C>T,p.R1022C	0.021	0.057	295|7	19|0	0.02387	368|9	X	39930400	39930400	G	A	background	BCOR	NM_001123385.2	6	c.3064C>T	p.Arg1022Cys	missense_variant					
-	KDM5C(1.3%)	exon17,c.2371C>A,p.L791I	0.013	0.014	721|9	91|0	0.00962	1029|10	X	53227817	53227817	G	T	background	KDM5C	NM_004187.5	17	c.2371C>A	p.Leu791Ile	missense_variant&splice_region_variant					
	KDM5C(1.5%)	exon13,c.1848C>T,p.N616=	0.015	0.043	380|5	27|0	0.01242	477|6	X	53231054	53231054	G	A	PASS	KDM5C	NM_004187.5	13	c.1848C>T	p.Asn616=	synonymous_variant					
-	KDM5C(1.2%)	exon5,c.649C>T,p.Q217*	0.012	0.026	515|5	50|0	0.00732	678|5	X	53246333	53246333	G	A	PASS	KDM5C	NM_004187.5	5	c.649C>T	p.Gln217*	stop_gained				COSV62890892	
	AMER1(5.0%)	exon2,c.228A>G,p.G76=	0.05	0.026	97|5	40|0	0.04386	109|5	X	63412939	63412939	T	C	distinguished	AMER1	NM_152424.4	2	c.228A>G	p.Gly76=	synonymous_variant				COSV57653801	
	TAF1(1.1%)	exon26,c.4048C>T,p.Q1350*	0.011	0.017	535|5	79|0	0.00814	731|6	X	70626537	70626537	C	T	PASS	TAF1	NM_004606.5	26	c.4048C>T	p.Gln1350*	stop_gained					
	ATRX(1.7%)	exon34,c.7137C>T,p.S2379=	0.017	0.02	332|5	64|0	0.01131	437|5	X	76776329	76776329	G	A	PASS	ATRX	NM_000489.6	34	c.7137C>T	p.Ser2379=	synonymous_variant					
